Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis | Synapse
March 3, 2026
Pulmonary hypertension prevalence and significance in lung transplant recipients with cystic fibrosis and non-cystic fibrosis bronchiectasis
AC
Abhimanyu Chandel
ST
Simon Turkington
CK
Christopher S. King
Ver todo
Puntos clave
Pulmonary hypertension prevalence is notably high in lung transplant recipients with cystic fibrosis.
The study specifically identifies a 40% prevalence of pulmonary hypertension among this population.
Observational analysis across various lung clinics evaluates the significance of pulmonary hypertension in patients.
These findings highlight the need for targeted monitoring and interventions for affected patients post-transplant.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Chandel et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75a94c6e9836116a20964
https://doi.org/https://doi.org/10.1016/j.chest.2025.12.047